Sign in Subscribe
Hotels and motels

Myriad Genetics to Present at Two Major Healthcare Conferences in June 2009

Strategic Insights

— 1 min read

Myriad Genetics, a leading healthcare company, has announced that Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., will present an overview of the company at two notable conferences in June 2009. The 8th Annual Needham Life Sciences Conference is scheduled for June 10, 2009, at the New York Palace Hotel, while the Goldman Sachs 30th Annual Global Healthcare Conference will take place on June 11, 2009, at the Grand Hyatt Hotel in New York City.

Key Takeaways:

  • Myriad Genetics will present at the 8th Annual Needham Life Sciences Conference on June 10, 2009, and the Goldman Sachs 30th Annual Global Healthcare Conference on June 11, 2009.
  • Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., will deliver the presentation.
  • Myriad Genetics is a healthcare company focused on developing and marketing novel molecular diagnostic and therapeutic products.
  • The company's news and information are available on its website at www.myriad.com.
  • Myriad's products and technologies include BRACAnalysis, Colaris, OnDose, and others.
  • The company has a portfolio of intellectual property, including patents and trademarks.
  • Myriad Genetics has a history of innovation in molecular diagnostics and therapeutics.
  • The company has raised concerns about risks and uncertainties associated with product development, sales, and regulatory approval.

Statistics:

  • Myriad Genetics is scheduled to present at two conferences in June 2009.
  • The 8th Annual Needham Life Sciences Conference will take place on June 10, 2009.
  • The Goldman Sachs 30th Annual Global Healthcare Conference will take place on June 11, 2009.
  • Myriad Genetics has a operating history dating back to at least June 30, 2008 (the date of its last reported financial year-end).
  • The company has made forward-looking statements about its product development and sales prospects.

Sources:

  • Myriad Genetics press release (May 28, 2009)
  • Myriad Genetics news and information available on the company's website (www.myriad.com)
  • Myriad's Annual Report on Form 10-K for the year ended June 30, 2008 (filed with the Securities and Exchange Commission)

Read more